FRBA vs CARE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 19, 2026

FRBA

58.0
AI Score
VS
CARE Wins

CARE

65.4
AI Score

Investment Advisor Scores

FRBA

58score
Recommendation
BUY

CARE

65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric FRBA CARE Winner
Forward P/E 8.3403 13.6612 FRBA
PEG Ratio 0 0 Tie
Revenue Growth 1.7% 68.3% CARE
Earnings Growth 5.1% 253.9% CARE
Tradestie Score 58.0/100 65.4/100 CARE
Profit Margin 31.7% 44.9% CARE
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD FRBA

Relative Price Performance (Last 90 Days)

FRBA 1M: +5.9% · 3M: +3.2% CARE 1M: +2.6% · 3M: -9.7%

Current Technical Phase

FRBA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 66.0 · Price: $18.55

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.2 · Price: $30.70

Fundamentals Snapshot

Metric FRBA CARE
Market Cap — —
Forward P/E 10.3 11.8
Trailing P/E 10.4 5.2
Revenue (TTM) — —
Revenue Growth 0.0% 0.7%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.6%
EPS 1.71 5.83
Dividend Yield 0.02% 0.00%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.